Onco-Innovations Extends Marketing Partnership with MCS

Onco-Innovations Limited, a company specializing in cancer research and treatment, has announced the extension of its engagement with MCS Market Communication Service GmbH. This partnership, originally detailed in a March 2025 press release, will continue to provide Onco-Innovations with a suite of online marketing services. These services include campaign creation, the production of marketing materials, and research and analytics. The arrangement is set to run until June 30, 2025, or until the budget is exhausted. A EUR 500,000 payment has been made to MCS for this continued collaboration.

The services will leverage digital channels such as Google Ads and native advertising to enhance Onco-Innovations' market presence. The company has confirmed that no securities have been exchanged as compensation to MCS or its principals. This move underscores Onco-Innovations' commitment to advancing its marketing efforts, aimed at reaching a broader audience in the oncology sector.